ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment (NCT07435155) | Clinical Trial Compass
RecruitingNot Applicable
ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment
Spain100 participantsStarted 2025-10-15
Plain-language summary
The goal of this observational study is to describe speech and breathing patterns in adults after acquired brain injury (ABI) and understand how these patterns relate to the presence, severity, and type of dysarthria. The main questions it aims to answer are:
* What changes in voice and breathing are observed in adults with dysarthria after ABI?
* Can combining acoustic, respiratory, and clinical assessments help identify dysarthria severity and subtype?
Participants will:
* Have their speech recorded to measure voice and articulation features, such as pitch, clarity, and the ability to sustain sounds.
* Perform breathing tests using a spirometer to assess lung function.
* Complete the Frenchay Dysarthria Assessment-2 (FDA-2), adapted to Spanish, to classify dysarthria type and severity.
About 97 to 101 participants will take part. The results will help speech therapists better detect, evaluate, and treat dysarthria in adults after brain injury.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years or older at the time of enrollment.
Diagnosed with acquired brain injury (ABI), including:
* Stroke
* Traumatic brain injury (TBI)
* Brain tumor
* Ability to provide written informed consent (or via a legally authorized representative if necessary).
* Cognitive function preserved, defined as a Mini-Mental State Examination (MMSE) score ≥ 24.
Exclusion Criteria:
* History of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) or asthma.
* History of hearing impairments that could affect speech evaluation.
* Presence of additional neurological or neurodegenerative disorders other than the acquired brain injury.
* History of voice disorders or dysphonia prior to the acquired brain injury.
* Presence of persistent pharyngeal symptoms, such as mucus, secretions, or foreign body sensation, which may interfere with speech assessment.
* Participants unable to comply with the assessment protocol or complete the required sessions.
* Presence of apahasia that prevents participation in speech tasks, such as reading, repetition, or spontaneous speech priduction.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Dysarthria severity assessed by the Frenchay Dysarthria Assessment-2 (FDA-2)